Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Groups In India Expect Supply Shortage Later This Year

This article was originally published in PharmAsia News

Executive Summary

The head of a pharmacy group in India expects a shortage of many drugs in India as of October, reaching as high as 80 percent by December. The general secretary of the All-India Organisation of Chemists and Druggists blames the coming shortage on the reduced bulk-drug supply from China and national price controls. He said his group expected the monthly business of pharmacies to drop by 75 percent during that period. Daara Patel, secretary in chief of the Indian Drug Manufacturers Association, said the pharmacies could see the absence of antibiotics and other drugs in the next few months due to the shortage of active pharmaceutical ingredients. (Click here for more

You may also be interested in...



Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief. 

WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency

The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.

Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector

With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel